Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101641-9 Myeloid sarcoma analysis Find Bld/Tiss Pt Doc FISH   ACTIVE Myeloid sarcoma analysis in Blood or Tissue by FISH   ADD DefinitionDescription                   MOLPATH   101641-9   FISH     Both       0 Myeloid sarcoma analysis Bld/T FISH       N   Blood; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Myelo; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.75 2.75                       0
101642-7 Cardiovascular risk panel - Ser/Plas Pt -     ACTIVE Cardiovascular risk panel - Serum or Plasma   ADD DefinitionDescription                   PANEL.MOLPATH   101642-7         Order       0 Cardiovascular risk pnl SerPl       N   Molecular pathology; MOLPATH; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.75   Panel                   0
101643-5 Cells.CD3^after stimulation with SARS-CoV-2 Nucleocapsid peptide NCnc Bld Pt Qn     TRIAL CD3 cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide   ADD DefinitionDescription     cells/uL             MICRO   101643-5         Both       0 CD3 Cells p COVID NuclCap # Bld       N   #; ABS; absolute; absolutes; Blood; CD3 Cells; Cell; Cells.CD3 p COVID NuclCap; Cellularity; Cnt; Count; Count/volume; CT; II; Leu4; Leu-4; Microbiology; Number concentration; Number Concentration (count/vol); p COVID NuclCap; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T3; WB; Whole blood 2.75 2.75       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101644-3 Cells.CD3+CD4+^after stimulation with SARS-CoV-2 Nucleocapsid peptide NCnc Bld Pt Qn     ACTIVE CD3+CD4+ (T4 helper) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide   ADD DefinitionDescription     cells/uL             MICRO   101644-3         Both       0 CD3+CD4+ Cells p COVID NuclCap # Bld       N   #; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD4+ Cells; CD3-CD4+; CD4+ T cells; Cell; Cells.CD3+CD4 + p COVID NuclCap; Cellularity; Cnt; Count; Count/volume; CT; Helper T cells; II; Inducer T cells; L3T4; Leu3; Leu-3; Leu4; Leu-4; Microbiology; Number concentration; Number Concentration (count/vol); p COVID NuclCap; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; T3; T4; T-4; T4 helper/inducer cells; W3/25; WB; Whole blood 2.75 2.75               {cells}/uL       0
101645-0 Cells.CD3+CD8+^after stimulation with Sars-CoV-2 nucleocapsid peptide NCnc Bld Pt Qn     ACTIVE CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide   ADD DefinitionDescription     cells/uL             MICRO   101645-0         Both       0 CD3+CD8+ Cells p COVID NuclCap # Bld       N   #; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; Cells.CD3+CD8+ p COVID NuclCap; Cellularity; Cnt; Count; Count/volume; CT; II; Leu2; Leu-2; Leu4; Leu-4; Microbiology; Number concentration; Number Concentration (count/vol); p COVID NuclCap; Pept; Point in time; QNT; Quan; Quant; Quantitative; Random; Severe Acute Respiratory Syndrome; Stim; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; WB; Whole blood 2.75 2.75               {cells}/uL       0
101646-8 Candida albicans+dubliniensis+parapsilosis+tropicalis DNA PrThr Vag Pt Ord Probe.amp.tar   ACTIVE Candida albicans, C. dubliniensis, C. parapsilosis, and C. tropicalis DNA [Presence] in Vaginal fluid by NAA with probe detection   ADD DefinitionDescription                   MICRO   101646-8   Probe.amp.tar     Both       0 Candida sp group DNA Vag Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; Cand; Candida sp group; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid 2.75 2.75                       0
101647-6 Ehrlichiosis & Anaplasmosis & Babesiosis & Borrelia miyamotoi DNA panel - Ser/Plas/Bld Pt - Probe.amp.tar   ACTIVE Ehrlichiosis and Anaplasmosis and Babesiosis and Borrelia miyamotoi DNA panel - Serum, Plasma or Blood by NAA with probe detection   NAM DefinitionDescription                   PANEL.MICRO   101647-6   Probe.amp.tar     Order       0 Tick Pnl SerPlBld NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B miyamotoi; B miyamotoi DNA; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TBRF; Tick Borne Diseases; Tick Pnl; tick-borne relapsing fever; TMA; Transcription mediated amplification; WB; Whole blood 2.76 2.75   Panel                   0
101648-4 14-3-3 Ag MCnc CSF Pt Qn IA   ACTIVE 14-3-3 Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay   ADD DefinitionDescription     ng/mL             CHEM   101648-4   IA     Both       0 14-3-3 Ag CSF IA-mCnc       N   Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; CJ; CJD; Creutzfeldt-Jacob Disease; Creutzfeldt-Jakob Disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; III; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS 2.75 2.75               ng/mL       0
101649-2 Tau protein MCnc CSF Pt Qn IA   ACTIVE Tau protein [Mass/volume] in Cerebral spinal fluid by Immunoassay   ADD DefinitionDescription     mg/dL             CHEM   101649-2   IA     Both       0 Tau Prot CSF IA-mCnc       N   Alzheimer disease; Alzheimer's disease; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS 2.75 2.75               mg/dL       0
10165-9 History of psychiatric symptoms & diseases Find ^Patient Pt Nar Reported   DEPRECATED Deprecated History of psychiatric symptoms and diseases Narrative   DEL DefinitionDescription                   H&P.HX   10165-9   Reported             0 Deprecated Psych symptoms & diseases Hx           Finding; Findings; H/O; H+P; H+P.HX; Hx; Narrative; P prime; Point in time; Psych symptoms & diseases Hx; Random; Report; Sx; Symp + dis 2.4 1.0i       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
101650-0 Prion disease risk Imp CSF Pt Nar IA   ACTIVE Prion disease risk [Interpretation] in Cerebral spinal fluid by Immunoassay Narrative   ADD DefinitionDescription                   CHEM   101650-0   IA     Both       0 Prion disease risk CSF IA-Imp       N   Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Dis; Diseases; Dz; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEIA; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS 2.75 2.75                       0
101651-8 MYC and BCL2 rearrangements Find Tiss Pt Doc FISH   ACTIVE MYC and BCL2 rearrangements in Tissue by FISH   ADD DefinitionDescription                   MOLPATH   101651-8   FISH     Observation       0 BLYM Tiss FISH       N   B-cell leukemia/lymphoma 2; BCL-2; BLYM; Burkitt lymphoma; Burkitts lymphoma; c-MYC; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Point in time; Protooncogene homologous to myelocytomatosis virus; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified; v-myc myelocytomatosis viral oncogene homolog 2.75 2.75                       0
101652-6 Somatotropin & glucose post glucose stimulation panel - Ser/Plas Pt -     ACTIVE Somatotropin and glucose post glucose stimulation panel - Serum or Plasma   MAJ DefinitionDescription                   PANEL.CHAL   101652-6         Order       0 GH + Glc pst Glc stim pnl SerPl       N   After; CHEMISTRY.CHALLENGE TESTING; GH; GH + Glc pst Glc stim pnl; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; Human growth hormone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; Stim 2.76 2.75   Panel                   0
101653-4 Prenatal hepatitis B & C panel - Ser/Plas Pt -     ACTIVE Prenatal hepatitis B and C panel - Serum or Plasma   ADD DefinitionDescription                   PANEL.MICRO   101653-4         Order       0 PHSP SerPl       N   Hep; Hepatis; Hepatit; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; PHSP; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.75 2.75   Panel                   0
101654-2 Neonatal ABO, Rh & DAT panel - Bld^Newborn Pt -     ACTIVE Neonatal ABO, Rh and DAT panel - Blood from Newborn   ADD DefinitionDescription                   PANEL.BLDBK   101654-2         Order       0 NEVAL Bld NB       N   Blood; BLOOD BANK; D phenotyping; D typing; NB; NEVAL; New born; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing; WB; Whole blood 2.75 2.75   Panel                   0
101655-9 Basic metabolic & hematocrit panel - Bld Pt -     ACTIVE Basic metabolic and hematocrit panel - Blood   PANEL DefinitionDescription                   PANEL.CHEM   101655-9         Order       0 Basic metabolic and hematocrit pnl Bld       N   Basic metabolic and hematocrit pnl; Blood; Chemistry; Hct; Pan; PANEL.CHEMISTRY; Panl; PCV; Pnl; Point in time; Random; WB; Whole blood 2.77 2.75   Panel                   0
101656-7 Lactate & pyruvate panel - Ser/Plas/Bld Pt -     ACTIVE Lactate and pyruvate panel - Serum, Plasma or Blood   ADD DefinitionDescription                   PANEL.CHEM   101656-7         Order       0 Lactate & pyruvate pnl SerPlBld       N   2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Blood; Chemistry; Lact; Lactate & pyruvate pnl; Lactic acid; L-lactate; Pan; PANEL.CHEMISTRY; Panl; Pl; PlasBld; Plasma; Plsm; Pnl; Point in time; Pyruvic acid; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood 2.75 2.75   Panel                   0
101657-5 Special investigation unit (SIU) medical record request Find ^Patient Pt Doc     ACTIVE Special investigation unit (SIU) medical record request Document   ADD DefinitionDescription                   DOC.MISC   101657-5         Both       0 SIU medical record request Doc       N   DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; SIU medical record request 2.75 2.75 Y                     0
101658-3 Cancer staging after multimodality therapy Find Cancer.XXX Pt Nom     ACTIVE Cancer staging after multimodality therapy   MIN DefinitionDescription                   ONCOLOGY   101658-3         Both       0 Ca staging aft multimodality thrpy       N   CA; Ca staging aft multimodality thrpy; Cancer; Finding; Findings; Misc; Miscellaneous; Nominal; ONCOLOGY; Other; Point in time; Random; Spec; TNM staging after multimodality therapy; To be specified in another part of the message; Unspecified 2.76 2.75                       0
101659-1 Cancer staging after tumor recurrence Find Cancer.XXX Pt Nom     ACTIVE Cancer staging after tumor recurrence   MIN DefinitionDescription                   ONCOLOGY   101659-1         Both       0 Cancer staging after tumor recurrence       N   CA; Cancer; Finding; Findings; Misc; Miscellaneous; Nominal; ONCOLOGY; Other; Point in time; Random; Spec; TNM staging after tumor recurrence; To be specified in another part of the message; Unspecified 2.76 2.75                       0
10166-7 Social function Hx ^Patient Pt Nar     ACTIVE History of Social function Narrative   NAM DefinitionDescription                   H&P.HX   10166-7                 0 Hx of Social function           FCN; Func; Funct; H+P; H+P.HX; History; Narrative; P prime; Point in time; Random; Report 2.56 1.0i                     Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision 0
101660-9 Cancer staging during autopsy Find Cancer.XXX Pt Nom     ACTIVE Cancer staging during autopsy   MIN DefinitionDescription                   ONCOLOGY   101660-9         Both       0 Cancer staging during autopsy       N   CA; Cancer; Finding; Findings; Misc; Miscellaneous; Nominal; ONCOLOGY; Other; Point in time; Random; Spec; TNM staging during autopsy; To be specified in another part of the message; Unspecified 2.76 2.75                       0
101661-7 Tumor marker level Find Ser Pt Nom     ACTIVE Tumor marker level Serum   MIN DefinitionDescription                   ONCOLOGY   101661-7         Both       0 Tumor marker level Ser       N   Cancer; Finding; Findings; Levels; Levl; LV; LVL; Mark; Nominal; ONCOLOGY; Point in time; Random; Serum; SR 2.76 2.75                       0
101662-5 Prion protein.abnormal PrThr CSF Pt Ord RT-QuIC   ACTIVE Abnormal Prion Protein [Presence] in Cerebral spinal fluid by RT-QuIC   ADD DefinitionDescription                   CHEM   101662-5   RT-QuIC     Both       0 Abn Prion Prot CSF Ql RT-QuIC       N   abn; Abn Prion Prot; abnorm; Bovine spongiform encephalopathy; BSE; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Ordinal; Point in time; PR; Prot; PrP; QL; Qual; Qualitative; Random; Scrapie; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.75 2.75                       0
101663-3 T-Cell acute lymphoblastic leukemia Find Bld/Tiss Pt Doc FISH   ACTIVE T-Cell acute lymphoblastic leukemia in Blood or Tissue by FISH   ADD DefinitionDescription                   MOLPATH   101663-3   FISH     Both       0 TALAF Bld/T FISH       N   Blood; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Point in time; Random; T cell; T prime; TALAF; TALMF; TALPF; Tissue; Tissue, unspecified; UCHL-1; WB; Whole blood; Whole blood or Tissue 2.75 2.75                       0
104,672 results found